Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?;Resonancia magnética de perfusión en astrocitomas de alto grado: el volumen sanguíneo cerebral, la altura del pico y el porcentaje de recuperación de intensidad de señal ¿pueden discriminar entre progresión y seudoprogresión?

Radiologia

Volumn 56, Issue 1, 2014, Pages 35-43

  Martinez Martinez A ^a   Martinez Bosch J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Astrocytoma; Brain perfusion; Brain tumors; Glioblastoma; Perfusion weighted magnetic resonance imaging; Pseudoprogression

Indexed keywords

ACCURACY; ARTICLE; ASTROCYTOMA; BRAIN BLOOD VOLUME; CASE CONTROL STUDY; DISEASE COURSE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; PERFUSION WEIGHTED IMAGING; RETROSPECTIVE STUDY; TUMOR BIOPSY; ADULT; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN NEOPLASMS; COMPARATIVE STUDY; FEMALE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ASTROCYTOMA; BLOOD VOLUME; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84891829579     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/j.rx.2013.02.006     Document Type: Article

References (40)

1. J. Fink, D. Born, and M.C. Chamberlain Pseudoprogression: relevance with respect to treatment of high-grade gliomas Curr Treat Options Oncol 12 2011 240 252
2. P. Sanghera, J. Perry, A. Sahgal, S. Symons, R. Aviv, and M. Morrison et al. Pseudoprogression following chemoradiotherapy for glioblastoma multiforme Can J Neurol Sci 37 2010 36 42
3. D. Brandsma, L. Stalpers, W. Taal, P. Sminia, and M.J. van den Bent Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461
4. G.M. Fatterpekar, D. Galheigo, A. Narayana, G. Johnson, and E. Knopp Treatment-related change versus tumor recurrence in high grade gliomas: a diagnostic conundrum-Use of dynamic susceptibility contrast-enhaced (DSC) perfusion MRI AJR Am J Roentgenol 198 2012 19 26
5. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
6. M.C. De Wit, H.G. de Bruin, W. Eijkenboom, P.A. Sillevis Smitt, and M.J. van den Bent Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression Neurology 63 2004 535 537
7. A. Jahangiri, and M.K. Aghi Pseudoprogression and treatment effect Neurosurg Clin N Am 23 2012 277 287
8. P. Pytel, and R.V. Lukas Update on diagnostic practice: tumors of the nervous system Arch Pathol Lab Med 133 2009 1062 1077
9. A. Fabi, M. Russillo, G. Metro, A. Vidiri, S. di Giovanni, and F. Cogentti Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice Anticancer Res 29 2009 2607 2610
10. P.Y. Wen, D.R. Macdonald, D.A. Reardon, T.F. Cloughesy, A.G. Sorensen, and E. Galanis et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
11. R. Mangla, G. Singh, D. Ziegelitz, M.T. Milano, D.N. Korones, and J. Zhong et al. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma Radiology 256 2010 575 584
12. R.J. Young, A. Gupta, A.D. Shah, J.J. Graber, Z. Zhang, and W. Shi et al. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma Neurology 76 2011 1918 1924
13. G.S. Young Advanced MRI of adult brain tumors Neurol Clin 25 2007 947 973
14. W. Chen Clinical applications of PET in brain tumors J Nucl Med 48 2007 1468 1481
15. D.P. Soares, and M. Law Magnetic resonance spectroscopy of the brain: Review of metabolites and clinical applications Clin Radiol 64 2009 12 21
16. E.R. Gerstner, A.G. Sorensen, R.K. Jain, and T.T. Batchelor Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas Curr Opin Neurol 21 2008 728 735
17. D.J. Covarrubias, B.R. Rosen, and M.H. Lev Dynamic magnetic resonance perfusion imaging of brain tumors Oncologist 9 2004 528 537
18. J.R. Petrella, and J.M. Provenzale MR perfusion imaging of the brain: techniques and applications AJR Am J Roentgenol 175 2000 207 219
19. J.A. Guzmán-de-Villoria, P. Fernández-García, J.M. Mateos-Pérez, and M. Desco Studying cerebral perfusion using magnetic susceptibility techniques: technique and applications Radiologia 54 2012 208 220
20. R. García-Figueiras, A.R. Padhani, J.C. Vilanova, V. Goh, Villalba, and C. Martín Imagen funcional tumoral. Parte 1 Radiologia 52 2010 115 125
21. L.C. Hygino da Cruz Jr., I. Rodríguez, R.C. Domingues, E.L. Gasparetto, and A.G. Sorensen Pseudoprogression and pseudoresponse: imaging challenges in the assessment of post treatment glioma AJNR Am J Neuroradiol 32 2011 1978 1985
22. E.S. Paulson, and K.M. Schmainda Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors Radiology 249 2008 601 613
23. R.F. Barajas Jr., J.S. Chang, M.R. Segal, A.T. Parsa, M.W. McDermott, and M.S. Berger et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Radiology 253 2009 486 496
24. R. Mangla, B. Kolar, T. Zhu, J. Zhong, J. Almast, and S. Ekholm Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain AJNR Am J Neuroradiol 32 2011 1004 1010
25. F.J. Meli, J. Ingui, F. Baldano, H. Martinetto, G. Sevlever, and A. Muggeri et al. Tumores oligodendrogliales: correlación entre el genotipo tumoral e imágenes de perfusión RM Neurorradiología 75 2011 9 13
26. G.S. Young, and K. Setayesh Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma AJNR Am J Neuroradiol 30 2009 575 577
27. M. Essig, F. Wenz, R. Scholdei, R. Brüning, C. Berchtenbreiter, and M. Meurer et al. Dynamic susceptibility contrast-enhaced echo-planar imaging of cerebral gliomas Acta Radiol 43 2002 354 359
28. A.P. Pathak, K.M. Schmainda, B.D. Ward, J.R. Linderman, K.J. Rebro, and A.S. Greene MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis Magn Reson Med 46 2001 735 747
29. J. Oh, R.G. Henry, A. Pirzkall, Y. Lu, X. Li, and I. Catalaa et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume J Magn Reson Imaging 19 2004 546 554
30. N.S. Akella, D.B. Twieg, T. Mikkelsen, F.H. Hochberg, S. Grossman, and G.A. Cloud et al. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial J Magn Reson Imaging 20 2004 913 922
31. J. Miller, H.H. Pien, D. Sahani, A.G. Sorensen, and J.H. Thrall Imaging angiogenesis: applications and potential for drug development J Natl Cancer Inst 97 2005 172 187
32. D. Brandsma, and M.J. van den Bent Pseudoprogression and pseudoresponse in the treatment of gliomas Curr Opin Neurol 22 2009 633 638
33. B. Bobek-Billewicz, G. Stasik-Pres, H. Majchrzak, and L. Zarudzki Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy Folia Neuropathol 48 2010 81 92
34. R. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
35. C.C. Quarles, and K.M. Schmainda Assessment of the morphological and functional effects of the antiangiogenic agent SU11657 on 9 L gliosarcoma vasculature using dynamic susceptibility contrast MRI Magn Reson Med 57 2007 680 687
36. R.J. Young, A. Gupta, A.D. Shah, J.J. Graber, T.A. Chan, and Z. Zhang et al. MRI perfusion in determining pseudoprogresion in patients with glioblastoma Clin Imaging 37 2013 41 49
37. G. Thompson, S.J. Mils, S.M. Stivaros, and A. Jackson Imaging of brain tumors: perfusion/permeability Neuroimaging Clin N Am 20 2010 337 353
38. S. Lacerda, and M. Law Magnetic resonance perfusion and permeability imaging in brain tumors Neuroimaging Clin N Am 19 2009 527 557
39. C. Tsien, C.J. Galbán, T.L. Chenever, T.D. Johnson, D.A. Hamstra, and P.C. Sundgren et al. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma J Clin Oncol 28 2010 2293 2299
40. *- weighted contrast-enhanced MRI Magn Reson Med 51 2004 961 968